logo
Select company
Select metric
$ -112.77MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
11
Sector
8
Industry
7
History
14
$ 5.87Close
$ 5.02 - $ 21.59 52-Week Range
Ticker Information

Ticker

TRDA

Company Name

ENTRADA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENTRADA THERAPEUTICS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TRDA - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -112.77M
3/31/2025$ -599K
12/31/2024$ 33.61M
9/30/2024$ 26.17M
6/30/2024$ 105.51M
3/31/2024$ -159.21M
12/31/2023$ 22.45M
9/30/2023$ -1.43M
6/30/2023$ -11.12M
3/31/2023$ 143.01M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENTRADA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 22.2M.
  • Over the past 5 years, ENTRADA THERAPEUTICS INC's average CF - Chg. Cash has been $ -1.94M.
  • The median CF - Chg. Cash for ENTRADA THERAPEUTICS INC during this period was $ -599K
  • ENTRADA THERAPEUTICS INC reached its highest CF - Chg. Cash over the past 5 years at $ 252.02M.
  • The lowest CF - Chg. Cash recorded by ENTRADA THERAPEUTICS INC in the same timeframe $ -241.96M

ENTRADA THERAPEUTICS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
ALEC : ALECTOR INC $ -2.47MSGMO : SANGAMO THERAPEUTICS INC $ 12.06MENTA : ENANTA PHARMACEUTICALS INC $ 8.43MADCT : ADC THERAPEUTICS SA $ -35.83MCDXS : CODEXIS INC $ 8.15MBDTX : BLACK DIAMOND THERAPEUTICS INC $ -2.82MSCPH : SCPHARMACEUTICALS INC $ 2.31MTHTX : THERATECHNOLOGIES INC $ -15.86MEDIT : EDITAS MEDICINE INC $ 74.1MFENC : FENNEC PHARMACEUTICALS INC $ -24.35M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

TRDA - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -241.96M

Minimum

Dec 31, 2022

$ 252.02M

Maximum

Dec 31, 2021

$ -1.94M

Average

$ -599K

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M